0001367644-20-000035.txt : 20200408
0001367644-20-000035.hdr.sgml : 20200408
20200408202214
ACCESSION NUMBER: 0001367644-20-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200406
FILED AS OF DATE: 20200408
DATE AS OF CHANGE: 20200408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Havey Adam
CENTRAL INDEX KEY: 0001514588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 20782957
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20853
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_158639171266875.xml
FORM 4
X0306
4
2020-04-06
0
0001367644
Emergent BioSolutions Inc.
EBS
0001514588
Havey Adam
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Business Operations
Common Stock
2020-04-06
4
S
0
4242
60
D
37986
D
Common Stock
2020-04-06
4
S
0
3730
60
D
34256
D
Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
/s/ S. Scott Lieberman, Attorney-in-fact
2020-04-08